Global Plasma-derived Therapies Supply, Demand and Key Producers, 2023-2029

Description

The global Plasma-derived Therapies market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.

This report studies the global Plasma-derived Therapies demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Plasma-derived Therapies, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Plasma-derived Therapies that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Plasma-derived Therapies total market, 2018-2029, (USD Million)
Global Plasma-derived Therapies total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Plasma-derived Therapies total market, key domestic companies and share, (USD Million)
Global Plasma-derived Therapies revenue by player and market share 2018-2023, (USD Million)
Global Plasma-derived Therapies total market by Type, CAGR, 2018-2029, (USD Million)
Global Plasma-derived Therapies total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Plasma-derived Therapies market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring LLC, Shire, Bayer, Kedrion, Takeda, Biotest, Octaparma, Bio Products Laboratory (BPL) and LFB, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Plasma-derived Therapies market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Plasma-derived Therapies Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Plasma-derived Therapies Market, Segmentation by Type
    Albumin
    Immunoglobulin
    Factor VIII
    Others

Global Plasma-derived Therapies Market, Segmentation by Application
    Hemophilia
    Primary Immunodeficiencies (PIDs)
    Idiopathic Thrombocytopenic Purpura (ITP)
    COVID-19
    Others

Companies Profiled:
    CSL Behring LLC
    Shire
    Bayer
    Kedrion
    Takeda
    Biotest
    Octaparma
    Bio Products Laboratory (BPL)
    LFB
    Grifols

Key Questions Answered
1. How big is the global Plasma-derived Therapies market?
2. What is the demand of the global Plasma-derived Therapies market?
3. What is the year over year growth of the global Plasma-derived Therapies market?
4. What is the total value of the global Plasma-derived Therapies market?
5. Who are the major players in the global Plasma-derived Therapies market?

Table of Contents

1 Supply Summary
    1.1 Plasma-derived Therapies Introduction
    1.2 World Plasma-derived Therapies Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Plasma-derived Therapies Total Market by Region (by Headquarter Location)
        1.3.1 World Plasma-derived Therapies Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Plasma-derived Therapies Market Size (2018-2029)
        1.3.3 China Plasma-derived Therapies Market Size (2018-2029)
        1.3.4 Europe Plasma-derived Therapies Market Size (2018-2029)
        1.3.5 Japan Plasma-derived Therapies Market Size (2018-2029)
        1.3.6 South Korea Plasma-derived Therapies Market Size (2018-2029)
        1.3.7 ASEAN Plasma-derived Therapies Market Size (2018-2029)
        1.3.8 India Plasma-derived Therapies Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Plasma-derived Therapies Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Plasma-derived Therapies Major Market Trends

2 Demand Summary
    2.1 World Plasma-derived Therapies Consumption Value (2018-2029)
    2.2 World Plasma-derived Therapies Consumption Value by Region
        2.2.1 World Plasma-derived Therapies Consumption Value by Region (2018-2023)
        2.2.2 World Plasma-derived Therapies Consumption Value Forecast by Region (2024-2029)
    2.3 United States Plasma-derived Therapies Consumption Value (2018-2029)
    2.4 China Plasma-derived Therapies Consumption Value (2018-2029)
    2.5 Europe Plasma-derived Therapies Consumption Value (2018-2029)
    2.6 Japan Plasma-derived Therapies Consumption Value (2018-2029)
    2.7 South Korea Plasma-derived Therapies Consumption Value (2018-2029)
    2.8 ASEAN Plasma-derived Therapies Consumption Value (2018-2029)
    2.9 India Plasma-derived Therapies Consumption Value (2018-2029)

3 World Plasma-derived Therapies Companies Competitive Analysis
    3.1 World Plasma-derived Therapies Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Plasma-derived Therapies Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Plasma-derived Therapies in 2022
        3.2.3 Global Concentration Ratios (CR8) for Plasma-derived Therapies in 2022
    3.3 Plasma-derived Therapies Company Evaluation Quadrant
    3.4 Plasma-derived Therapies Market: Overall Company Footprint Analysis
        3.4.1 Plasma-derived Therapies Market: Region Footprint
        3.4.2 Plasma-derived Therapies Market: Company Product Type Footprint
        3.4.3 Plasma-derived Therapies Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Plasma-derived Therapies Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Plasma-derived Therapies Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Plasma-derived Therapies Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Plasma-derived Therapies Consumption Value Comparison
        4.2.1 United States VS China: Plasma-derived Therapies Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Plasma-derived Therapies Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Plasma-derived Therapies Companies and Market Share, 2018-2023
        4.3.1 United States Based Plasma-derived Therapies Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Plasma-derived Therapies Revenue, (2018-2023)
    4.4 China Based Companies Plasma-derived Therapies Revenue and Market Share, 2018-2023
        4.4.1 China Based Plasma-derived Therapies Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Plasma-derived Therapies Revenue, (2018-2023)
    4.5 Rest of World Based Plasma-derived Therapies Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Plasma-derived Therapies Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Plasma-derived Therapies Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Plasma-derived Therapies Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Albumin
        5.2.2 Immunoglobulin
        5.2.3 Factor VIII
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Plasma-derived Therapies Market Size by Type (2018-2023)
        5.3.2 World Plasma-derived Therapies Market Size by Type (2024-2029)
        5.3.3 World Plasma-derived Therapies Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Plasma-derived Therapies Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hemophilia
        6.2.2 Primary Immunodeficiencies (PIDs)
        6.2.3 Idiopathic Thrombocytopenic Purpura (ITP)
        6.2.4 COVID-19
        6.2.5 COVID-19
    6.3 Market Segment by Application
        6.3.1 World Plasma-derived Therapies Market Size by Application (2018-2023)
        6.3.2 World Plasma-derived Therapies Market Size by Application (2024-2029)
        6.3.3 World Plasma-derived Therapies Market Size by Application (2018-2029)

7 Company Profiles
    7.1 CSL Behring LLC
        7.1.1 CSL Behring LLC Details
        7.1.2 CSL Behring LLC Major Business
        7.1.3 CSL Behring LLC Plasma-derived Therapies Product and Services
        7.1.4 CSL Behring LLC Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 CSL Behring LLC Recent Developments/Updates
        7.1.6 CSL Behring LLC Competitive Strengths & Weaknesses
    7.2 Shire
        7.2.1 Shire Details
        7.2.2 Shire Major Business
        7.2.3 Shire Plasma-derived Therapies Product and Services
        7.2.4 Shire Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Shire Recent Developments/Updates
        7.2.6 Shire Competitive Strengths & Weaknesses
    7.3 Bayer
        7.3.1 Bayer Details
        7.3.2 Bayer Major Business
        7.3.3 Bayer Plasma-derived Therapies Product and Services
        7.3.4 Bayer Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Bayer Recent Developments/Updates
        7.3.6 Bayer Competitive Strengths & Weaknesses
    7.4 Kedrion
        7.4.1 Kedrion Details
        7.4.2 Kedrion Major Business
        7.4.3 Kedrion Plasma-derived Therapies Product and Services
        7.4.4 Kedrion Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Kedrion Recent Developments/Updates
        7.4.6 Kedrion Competitive Strengths & Weaknesses
    7.5 Takeda
        7.5.1 Takeda Details
        7.5.2 Takeda Major Business
        7.5.3 Takeda Plasma-derived Therapies Product and Services
        7.5.4 Takeda Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Takeda Recent Developments/Updates
        7.5.6 Takeda Competitive Strengths & Weaknesses
    7.6 Biotest
        7.6.1 Biotest Details
        7.6.2 Biotest Major Business
        7.6.3 Biotest Plasma-derived Therapies Product and Services
        7.6.4 Biotest Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Biotest Recent Developments/Updates
        7.6.6 Biotest Competitive Strengths & Weaknesses
    7.7 Octaparma
        7.7.1 Octaparma Details
        7.7.2 Octaparma Major Business
        7.7.3 Octaparma Plasma-derived Therapies Product and Services
        7.7.4 Octaparma Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Octaparma Recent Developments/Updates
        7.7.6 Octaparma Competitive Strengths & Weaknesses
    7.8 Bio Products Laboratory (BPL)
        7.8.1 Bio Products Laboratory (BPL) Details
        7.8.2 Bio Products Laboratory (BPL) Major Business
        7.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Product and Services
        7.8.4 Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Bio Products Laboratory (BPL) Recent Developments/Updates
        7.8.6 Bio Products Laboratory (BPL) Competitive Strengths & Weaknesses
    7.9 LFB
        7.9.1 LFB Details
        7.9.2 LFB Major Business
        7.9.3 LFB Plasma-derived Therapies Product and Services
        7.9.4 LFB Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 LFB Recent Developments/Updates
        7.9.6 LFB Competitive Strengths & Weaknesses
    7.10 Grifols
        7.10.1 Grifols Details
        7.10.2 Grifols Major Business
        7.10.3 Grifols Plasma-derived Therapies Product and Services
        7.10.4 Grifols Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Grifols Recent Developments/Updates
        7.10.6 Grifols Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Plasma-derived Therapies Industry Chain
    8.2 Plasma-derived Therapies Upstream Analysis
    8.3 Plasma-derived Therapies Midstream Analysis
    8.4 Plasma-derived Therapies Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Plasma-derived Therapies Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Plasma-derived Therapies Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Plasma-derived Therapies Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Plasma-derived Therapies Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Plasma-derived Therapies Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Plasma-derived Therapies Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Plasma-derived Therapies Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Plasma-derived Therapies Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Plasma-derived Therapies Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Plasma-derived Therapies Players in 2022
    Table 12. World Plasma-derived Therapies Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Plasma-derived Therapies Company Evaluation Quadrant
    Table 14. Head Office of Key Plasma-derived Therapies Player
    Table 15. Plasma-derived Therapies Market: Company Product Type Footprint
    Table 16. Plasma-derived Therapies Market: Company Product Application Footprint
    Table 17. Plasma-derived Therapies Mergers & Acquisitions Activity
    Table 18. United States VS China Plasma-derived Therapies Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Plasma-derived Therapies Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Plasma-derived Therapies Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Plasma-derived Therapies Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Plasma-derived Therapies Revenue Market Share (2018-2023)
    Table 23. China Based Plasma-derived Therapies Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Plasma-derived Therapies Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Plasma-derived Therapies Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Plasma-derived Therapies Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Plasma-derived Therapies Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Plasma-derived Therapies Revenue Market Share (2018-2023)
    Table 29. World Plasma-derived Therapies Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Plasma-derived Therapies Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Plasma-derived Therapies Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Plasma-derived Therapies Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Plasma-derived Therapies Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Plasma-derived Therapies Market Size by Application (2024-2029) & (USD Million)
    Table 35. CSL Behring LLC Basic Information, Area Served and Competitors
    Table 36. CSL Behring LLC Major Business
    Table 37. CSL Behring LLC Plasma-derived Therapies Product and Services
    Table 38. CSL Behring LLC Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. CSL Behring LLC Recent Developments/Updates
    Table 40. CSL Behring LLC Competitive Strengths & Weaknesses
    Table 41. Shire Basic Information, Area Served and Competitors
    Table 42. Shire Major Business
    Table 43. Shire Plasma-derived Therapies Product and Services
    Table 44. Shire Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Shire Recent Developments/Updates
    Table 46. Shire Competitive Strengths & Weaknesses
    Table 47. Bayer Basic Information, Area Served and Competitors
    Table 48. Bayer Major Business
    Table 49. Bayer Plasma-derived Therapies Product and Services
    Table 50. Bayer Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Bayer Recent Developments/Updates
    Table 52. Bayer Competitive Strengths & Weaknesses
    Table 53. Kedrion Basic Information, Area Served and Competitors
    Table 54. Kedrion Major Business
    Table 55. Kedrion Plasma-derived Therapies Product and Services
    Table 56. Kedrion Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Kedrion Recent Developments/Updates
    Table 58. Kedrion Competitive Strengths & Weaknesses
    Table 59. Takeda Basic Information, Area Served and Competitors
    Table 60. Takeda Major Business
    Table 61. Takeda Plasma-derived Therapies Product and Services
    Table 62. Takeda Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Takeda Recent Developments/Updates
    Table 64. Takeda Competitive Strengths & Weaknesses
    Table 65. Biotest Basic Information, Area Served and Competitors
    Table 66. Biotest Major Business
    Table 67. Biotest Plasma-derived Therapies Product and Services
    Table 68. Biotest Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Biotest Recent Developments/Updates
    Table 70. Biotest Competitive Strengths & Weaknesses
    Table 71. Octaparma Basic Information, Area Served and Competitors
    Table 72. Octaparma Major Business
    Table 73. Octaparma Plasma-derived Therapies Product and Services
    Table 74. Octaparma Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Octaparma Recent Developments/Updates
    Table 76. Octaparma Competitive Strengths & Weaknesses
    Table 77. Bio Products Laboratory (BPL) Basic Information, Area Served and Competitors
    Table 78. Bio Products Laboratory (BPL) Major Business
    Table 79. Bio Products Laboratory (BPL) Plasma-derived Therapies Product and Services
    Table 80. Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Bio Products Laboratory (BPL) Recent Developments/Updates
    Table 82. Bio Products Laboratory (BPL) Competitive Strengths & Weaknesses
    Table 83. LFB Basic Information, Area Served and Competitors
    Table 84. LFB Major Business
    Table 85. LFB Plasma-derived Therapies Product and Services
    Table 86. LFB Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. LFB Recent Developments/Updates
    Table 88. Grifols Basic Information, Area Served and Competitors
    Table 89. Grifols Major Business
    Table 90. Grifols Plasma-derived Therapies Product and Services
    Table 91. Grifols Plasma-derived Therapies Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Plasma-derived Therapies Upstream (Raw Materials)
    Table 93. Plasma-derived Therapies Typical Customers
List of Figure
    Figure 1. Plasma-derived Therapies Picture
    Figure 2. World Plasma-derived Therapies Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Plasma-derived Therapies Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Plasma-derived Therapies Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Plasma-derived Therapies Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Plasma-derived Therapies Revenue (2018-2029) & (USD Million)
    Figure 13. Plasma-derived Therapies Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Plasma-derived Therapies Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Plasma-derived Therapies Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Plasma-derived Therapies by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Plasma-derived Therapies Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Plasma-derived Therapies Markets in 2022
    Figure 27. United States VS China: Plasma-derived Therapies Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Plasma-derived Therapies Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Plasma-derived Therapies Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Plasma-derived Therapies Market Size Market Share by Type in 2022
    Figure 31. Albumin
    Figure 32. Immunoglobulin
    Figure 33. Factor VIII
    Figure 34. Others
    Figure 35. World Plasma-derived Therapies Market Size Market Share by Type (2018-2029)
    Figure 36. World Plasma-derived Therapies Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Plasma-derived Therapies Market Size Market Share by Application in 2022
    Figure 38. Hemophilia
    Figure 39. Primary Immunodeficiencies (PIDs)
    Figure 40. Idiopathic Thrombocytopenic Purpura (ITP)
    Figure 41. COVID-19
    Figure 42. Others
    Figure 43. Plasma-derived Therapies Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols